Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Free Cash Flow : -193.82M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -193.82M |
| March 31, 2026 | -172.93M |
| December 31, 2025 | -156.75M |
| September 30, 2025 | -129.49M |
| Date | Value |
|---|---|
| June 30, 2025 | -97.71M |
| March 31, 2025 | -74.22M |
| December 31, 2024 | -55.08M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Korsana Biosciences, Inc. | -4.517M |
| IRulya Therapeutics, Inc. | -47.00M |
| PepGen Inc. | -69.46M |
| Q32 Bio, Inc. | -19.83M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.36M |
| Cash from Investing (Quarterly) | 45.73M |
| Cash from Financing (Quarterly) | 0.037M |
| Free Cash Flow Per Share (Quarterly) | -554.41 |
| Free Cash Flow to Equity (Quarterly) | -44.28M |
| Free Cash Flow to Firm (Quarterly) | -44.41M |
| Free Cash Flow Yield | -239.3% |